Robert Krayn Put the Spreadsheet in Service of the Waiting Room

Robert Krayn spent his first career deciding whether other people's promises would pay. Credit analysis has a wonderfully impolite habit: it ignores the brochure and asks who owes what, when, and with whose money. By the time he became a founder, Krayn had worked at Bank of New York Mellon, in mergers and acquisitions at Guggenheim Partners, and for five years at MidOcean Partners. There, as a vice president and senior analyst, he oversaw a $300 million portfolio of high-yield bonds, equities, and derivatives across consumer, retail, healthcare, and other sectors. Then he moved from examining operating systems to building one.

The company was Talkiatry, co-founded with psychiatrist Georgia Gaveras and launched in April 2020. The timing could scarcely have been more dramatic, but the idea beneath it was stubbornly practical. Psychiatry was difficult to navigate, clinicians were buried in administrative work, and insurance coverage often failed at the precise moment it was meant to become useful. Krayn did not propose another directory with serene colors and a hopeful search box. He and Gaveras designed a medical practice that would employ clinicians, negotiate with insurers, and build technology around the work.

Gaveras once captured their division of labor with the economy of a good sitcom: “He's the money, I'm the medicine.” It is funny because it is tidy, and revealing because the company would need both. A national practice cannot be financed by bedside manner alone. Nor can a spreadsheet supervise a clinical decision. Talkiatry's model depends on keeping those competencies close enough to argue productively.

“There are no shortcuts. And you have to really choose. Are you building a consumer company, or are you building a health care company?”Robert Krayn, 2024

The expensive answer was the point

Krayn's answer to his own question was the healthcare company. That decision sounds abstract until it arrives as payroll. Talkiatry hires clinicians as employees rather than treating them as names in a marketplace. It signs contracts with payers. It creates layers of clinical oversight. It invests in systems for intake, scheduling, billing, and measurement. The company has said it does not charge subscription fees or maintain pharmacy affiliations. Its money comes through familiar healthcare channels, including traditional reimbursement and arrangements tied to performance.

In startup shorthand, this is “full stack.” In ordinary English, it means accepting responsibility for more of the mess. The arrangement is capital intensive. It also gives the company more control over training, tools, availability, and data. In March 2026, Krayn told Behavioral Health Business that the W-2 employment model was central to maintaining quality at scale. Investors, he said, were not merely looking for growth: “They're looking for scale. They're looking for you to operate appropriately. But they're also looking for good outcomes.”

The phrase “operate appropriately” is pure Krayn. It is not lyrical. It is better: it exposes the standard underneath the sales pitch. He tends to speak about digital health as a set of accountable systems, not a parade of features. In a 2022 TechCrunch essay co-written with Ramkumar Iyer, his subject was how clinical expertise belongs inside a digital-health business model. The argument was not that technology should vanish. It was that software without clinical judgment can optimize the wrong thing with admirable speed.

A balance sheet learns to speak clinical

Krayn graduated summa cum laude from Rutgers University with a bachelor's degree in finance. The discipline remained visible after he changed industries. He talks about payer relationships in the language of evidence, incentives, and total cost. He describes measurement-based care as a precursor to value-based care. Access may open the door, in his telling, but results determine whether insurers continue to value the arrangement.

The funding history resembles a staircase built while people were climbing it. Talkiatry announced a $5 million Series A in February 2021. A $37 million raise followed in 2022, when the practice employed 140 psychiatrists. In June 2024, Andreessen Horowitz led a $130 million equity-and-debt financing round; Talkiatry then operated in 43 states, employed more than 300 psychiatrists, and worked with over 60 payers. In February 2026, the company announced an oversubscribed $210 million Series D led by Perceptive Advisors and said its full-time psychiatrist roster had passed 800.

The latest round was not presented as confetti. Krayn told STAT that part of its purpose was resilience: a financial cushion for a company carrying a large employed workforce if reimbursement were interrupted. He pointed to the 2024 Change Healthcare ransomware attack, which delayed payments across the industry. It is a credit analyst's observation hiding in a founder's update. Growth capital can buy expansion. It can also buy enough time to make payroll when somebody else's plumbing bursts.

The founder goes to the rulebook

In September 2023, Krayn and Gaveras appeared at a Drug Enforcement Administration listening session on telemedicine policy. Krayn began by asking Administrator Anne Milgram for a handshake. Then he set out the practice's operating statistics: more than 300 board-certified psychiatrists at the time, formal clinical supervision, continuing-medical-education accreditation, insurer partnerships, and regular appointments. It was advocacy by inventory. The details made the argument.

The appearance also showed another side of the job. A founder building in regulated healthcare cannot remain on the cheerful side of the website. Rules about remote care shape who can be seen, what clinicians can do, and whether a national operating model continues to work. Krayn has argued publicly for preserving access while maintaining physician oversight. Whatever one thinks of the policy, his method is consistent: define the machinery, show the controls, then make the case.

“The health care company comes first.”Robert Krayn on the choice behind Talkiatry

That same preference governs his treatment of artificial intelligence. Talkiatry uses AI in administrative operations, including parts of revenue-cycle work and insurance discovery, and offers tools such as AI scribes. Krayn has said clinicians are not forced to use them. Gaveras has described a process in which clinicians identify and test tools, then carry lessons back to leadership. The arrangement puts software in the position of assistant, where software is often at its most useful and least theatrical.

What the numbers cannot decide

The risk in admiring a system is forgetting whom the system serves. Krayn's public vocabulary - outcomes, scale, cost, measurement - can sound chilly when separated from its object. Yet his point is that access without quality is an incomplete achievement. By 2024, he was arguing that payer networks had grown more robust and that simple availability no longer distinguished a company. The next contest would concern what care changes, how reliably it changes it, and whether those changes reduce costs elsewhere.

This is why the partnership with Gaveras matters beyond the pleasant symmetry of their job titles. Finance can locate a broken incentive. Clinical leadership must decide what good practice looks like once the incentive is repaired. Talkiatry's business proposition is that those two forms of judgment can live inside one organization, with proprietary technology connecting them rather than pretending to replace either.

Krayn was named to Behavioral Health Business's Future Leaders class in 2024. Asked what future leaders require, he answered with one word that a credit committee would appreciate: adaptability. He also said he would tell his younger self to keep going. Early observers had warned that others were already pursuing similar ideas. His focus on psychiatrists looked contrarian. Years later, that focus had become the company's identifying feature.

There is a mild irony here. Founders are rewarded for speaking as though the future arrived in their notebook fully formed. Krayn's record is more interesting because it looks iterative: start with the reimbursement problem, build the clinical partnership, employ the workforce, create the tools, measure the result, raise the next block of capital, repeat. Each stage makes the next more plausible and more expensive.

He has also been willing to add distribution without pretending Talkiatry must own every doorway. A 2024 partnership let people using BetterHelp through their employers move into Talkiatry's psychiatric network, while hospital relationships created another path into the practice. Krayn described the pairing as a way to cover more needs while keeping care in-network. It was a characteristically structural answer to a consumer problem: make the handoff work, let each organization do the job it is built to do, and reduce the financial surprise at the other end. The partnership did not need a new philosophy. It needed plumbing between two established systems.

The $210 million round provides a very large answer to the question of whether investors believe the model can continue. It does not settle the harder questions about quality, costs, or endurance; no financing can. Krayn's own maxim is the useful one: there are no shortcuts. For a founder trained to examine promises, the next obligation is familiar. The numbers must keep paying.